In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

Three speakers outlined how AI is likely to have a major impact on the future of preventive cardiology.At the American ...

The American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society have developed a registry that aims to ...

The FDA has approved Wegovy for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis ...

When I attended Franklin & Marshall College in Lancaster, Pennsylvania, I was pre-med mainly for the fun of getting to say, ...

Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...

LaShae D. Rolle, MPH, CPH, a national powerlifting champion, went to the gym to train less than 24 hours after receiving her ...

The field of cardiovascular disease prevention has made great strides in the 8 years since publication of the last U.S. blood ...

Wearing orthokeratology contact lenses for 11 years led to a substantial reduction in axial length, with a mean treatment ...